SecBot SecBot
8-K ·Filed Jun 30, 2026

NUMD

Nu-Med Plus, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed3mo ago SEC0001575872-26-000459
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▲ Bullish

This is a transformative reverse merger into gold mining. The massive potential dilution (up to 110M new common shares from preferred conversions alone, plus up to 10% more from the true-up) against a micro-cap base of 83.5M shares outstanding creates extreme uncertainty. Monitor for closing by July 8 deadline, shareholder approval of the reverse split and authorized share increase, and any subsequent capital raise for exploration. The stock will likely trade on the gold story rather than fundamentals until resource updates emerge.

DirectionBullish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
NUMD ▲ +98.28% at T+60d
LONG call ✓ call won +98.28% · α vs SPY +94.44% · entry $0.0116 → $0.0230
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+12.26%
call +12.26% · α +12.40%
$0.0130
settled 4mo ago
T+5d
+56.21%
call +56.21% · α +56.08%
$0.0181
settled 4mo ago
T+20d
+58.62%
call +58.62% · α +59.41%
$0.0184
settled 3mo ago
T+60d
+98.28%
call +98.28% · α +94.44%
$0.0230
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Nu-Med Plus (NUMD) entered into a Share Exchange Agreement to acquire 100% of Avid Gold Ltd, a UK gold exploration company, in exchange for 4,500,000 shares of Series A Preferred Stock (convertible into 90M common shares) and repayment of a $100,000 promissory note. Concurrently, the company signed a Mineral Property Purchase Agreement to acquire six gold properties in Canada from MegumaGold Corp. for 500,000 Series A Preferred Shares (convertible into 10M common shares), with a contingent value mechanism guaranteeing the vendor at least $3M in proceeds over three years. The transactions represent a transformative reverse merger into gold mining, shifting the company away from its medical device roots, with post-closing shareholder votes required for a 1-for-27 reverse split, authorized share increase to 500M, and redomicile to Nevada.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Acquires 100% of Avid Gold Ltd for 4.5M Series A Preferred shares (convertible into 90M common shares at 20:1) plus repayment of $100K promissory note
  • Acquires six gold properties in Nova Scotia, New Brunswick, and Newfoundland from MegumaGold Corp. for 500K Series A Preferred shares (convertible into 10M common shares)
  • Properties have historical NI 43-101 resource estimates of 45,391 oz Indicated and 576,942 oz Inferred gold (622,332 oz total)
  • Contingent value right: if vendor receives <$3M from share sales by 3rd anniversary, company must issue additional common shares up to 10% of outstanding
  • Post-closing shareholder votes required: 1-for-27 reverse split, authorized common increase from 90M to 500M shares, and redomicile from Utah to Nevada
  • 1M shares of Series X Super Voting Preferred Stock (100 votes each) to be issued to new President Emma Priestley
  • Closing required by July 8, 2026, subject to conditions including registration rights and voting agreements
  • Additional 225K Series A shares each to CEO Hayde and CFO Merrell, and 50K to Hock, for services rendered

Financial Impact

Transformative acquisition of gold exploration assets with historical resource of 622,332 oz gold; consideration is all stock (no cash) with a $3M floor value guarantee to the vendor over 3 years

dilutionshare countbusiness modelcapital structure

Risk Factors

  • Massive dilution: full conversion of all Series A shares would add up to 110M common shares (132% dilution from current 83.5M outstanding), plus potential true-up shares up to 10% of outstanding
  • Closing risk: transaction requires multiple conditions including shareholder votes, regulatory approvals, and MegumaGold shareholder approval for the property acquisition
  • Exploration risk: gold properties are early-stage with no current production; historical resource estimates may not be current or economic
  • Reverse split and authorized share increase could be voted down by shareholders
  • Company has no disclosed revenue from gold operations and limited cash; will likely need additional financing

Market Snapshot

Exchange
OTC
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001575872-26-000459
Document: numd002_ex10-1.htm0001575872-26-000459
Document: numd002_ex3-1.htm0001575872-26-000459
Document: numd002_ex3-3.htm0001575872-26-000459
Document: numd002_ex3-2.htm0001575872-26-000459
Document: 0001575872-26-000459-index-headers.html0001575872-26-000459
Document: 0001575872-26-000459-index.html0001575872-26-000459
Document: 0001575872-26-000459.txt0001575872-26-000459
3 reports for NUMD
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for NUMD — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
8-K
BEARISH ★ 6/10
$0.007200 $0.007200· 0.00%▲ +0.53%$0.007200 (+0.00%)
Aug 25, 2026
8w ago
8-K
BULLISH ★ 7/10
$0.0244 $0.0230▼ −5.74%▼ −5.76%$0.007200 (−70.49%)
Jun 30, 2026
16w ago
8-K
BULLISH ★ 7/10
$0.0116 $0.0130▲ +12.26%▲ +12.40%$0.007200 (−37.93%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 8h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026